New ICD-9 Code Effective Oct. 1

The next ICD-9-CM update will be effective Oct. 1. It’s been a year since the last update (there were no updates on April 1)—and if you blinked, you would miss this one. “One” being the operative word, as the 2013 final addenda to Volume 3 adds just one new code.

In the tabular section, add new code:
00.95  Injection or infusion of glucarpidase

In the index, under:
Infusion (intra-anterial) (intravenous)

  • add subterm glucarpidase 00.95
  • add subterm Voraxaze® 00.95

In the index, under:
Injection (into) (hyperdermically) (intramuscularly) (intravenously) (acting locally or systemically)

  • add subterm glucarpidase 00.95
  • add subterm Voraxaze® 00.95

Glucarpidase injection (Voraxaze®, BTG International Inc.) was approved by the U.S. Food and Drug Administration on Jan. 17, 2012 for the treatment of toxic plasma methotrexate concentrations (> 1 micromole per liter) in patients with delayed methotrexate clearance due to impaired renal function.

ICD-9-CM updates and revisions can be found on the Centers for Medicare & Medicaid Services (CMS) website. At this time, updates to ICD-9-CM are being made to accommodate new technology only. ICD-9-CM updates will cease once ICD-10 is implemented.

Latest posts by admin aapc (see all)

Read the complete Article

Login as a member or sign up for free to get uninterrupted access to AAPC blog posts and stay updated on industry news through our monthly newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *